Section of Structural Biology, The Institute of Cancer Research, Chester Beatty Laboratories, London, UK.
EMBO J. 2011 Mar 2;30(5):894-905. doi: 10.1038/emboj.2011.18. Epub 2011 Feb 11.
Ire1 (Ern1) is an unusual transmembrane protein kinase essential for the endoplasmic reticulum (ER) unfolded protein response (UPR). Activation of Ire1 by association of its N-terminal ER luminal domains promotes autophosphorylation by its cytoplasmic kinase domain, leading to activation of the C-terminal ribonuclease domain, which splices Xbp1 mRNA generating an active Xbp1s transcriptional activator. We have determined the crystal structure of the cytoplasmic portion of dephosphorylated human Ire1α bound to ADP, revealing the 'phosphoryl-transfer' competent dimeric face-to-face complex, which precedes and is distinct from the back-to-back RNase 'active' conformation described for yeast Ire1. We show that the Xbp1-specific ribonuclease activity depends on autophosphorylation, and that ATP-competitive inhibitors staurosporin and sunitinib, which inhibit autophosphorylation in vitro, also inhibit Xbp1 splicing in vivo. Furthermore, we demonstrate that activated Ire1α is a competent protein kinase, able to phosphorylate a heterologous peptide substrate. These studies identify human Ire1α as a target for development of ATP-competitive inhibitors that will modulate the UPR in human cells, which has particular relevance for myeloma and other secretory malignancies.
IRE1(ERN1)是一种特殊的跨膜蛋白激酶,对内质网(ER)未折叠蛋白反应(UPR)至关重要。IRE1 的激活是通过其 N 端 ER 腔域的结合促进其细胞质激酶域的自身磷酸化,导致 C 端核糖核酸酶域的激活,该酶将 Xbp1 mRNA 拼接生成活性 Xbp1s 转录激活物。我们已经确定了去磷酸化人 IRE1α 与 ADP 结合的细胞质部分的晶体结构,揭示了“磷酸转移”功能齐全的面对面二聚体复合物,该复合物先于并不同于酵母 IRE1 描述的背对背核糖核酸酶“活性”构象。我们表明,Xbp1 特异性核糖核酸酶活性依赖于自身磷酸化,并且体外抑制自身磷酸化的 STAU 和 SU 等 ATP 竞争性抑制剂也抑制体内 Xbp1 的剪接。此外,我们证明激活的 IRE1α 是一种有能力的蛋白激酶,能够磷酸化异源肽底物。这些研究确定了人 IRE1α 是开发 ATP 竞争性抑制剂的靶标,这些抑制剂将调节人细胞中的 UPR,这对骨髓瘤和其他分泌性恶性肿瘤具有特殊意义。